Elevated serum S-100B levels in children with temporal lobe epilepsy
Mustafa Calik1, Mahmut Abuhandan, Abdurrahman Sonmezler
1Harran University School of Medicine, Department of Pediatric Neurology, Sanliurfa 63100, Turkey. m.calik80@hotmail.com
Seizure
|November 14, 2012
Summary
Serum S-100B protein levels are elevated in children with temporal lobe epilepsy, indicating potential neuronal damage. This finding supports its use as a biomarker for pediatric neurological conditions.
Area of Science:
- Neurology
- Biochemistry
- Pediatrics
Background:
- Serum S-100B protein is a recognized marker for nervous system damage.
- Previous studies have focused on adult populations, leaving a gap in pediatric research.
- Temporal lobe epilepsy (TLE) in children requires reliable biomarkers for assessing neurological injury.
Purpose of the Study:
- To investigate serum S-100B protein levels in pediatric patients diagnosed with temporal lobe epilepsy.
- To establish whether S-100B protein concentration differs between children with TLE and healthy controls.
- To explore the potential of S-100B as a biomarker for neuronal damage in pediatric TLE.
Main Methods:
- A case-controlled cross-sectional study involving 19 children with TLE and 25 healthy controls.
- Serum samples were collected within 30 minutes post-seizure.
- S-100B protein levels were quantified using electrochemiluminescence immunoassay (ECLIA).
Main Results:
- Children with TLE exhibited significantly higher mean serum S-100B protein levels (0.12±0.02 μg/L) compared to healthy controls (0.07±0.01 μg/L).
- The difference in S-100B levels between the groups was statistically significant (P<0.001).
Conclusions:
- Elevated serum S-100B protein levels in children with TLE suggest ongoing neuronal damage.
- These findings align with previous research in adult TLE patients.
- S-100B protein may serve as a valuable biomarker for assessing brain injury in pediatric TLE.
